Partnership with Pfizer Gero recently entered into a research collaboration with Pfizer, Inc., demonstrating a commitment to developing treatments for age-related diseases and expanding its network within the pharmaceutical industry.
Investments from Melnichek and others Gero secured a $6 million Series A extension round with funding from Melnichek Investments and other investors, indicating a strong financial backing and potential for further growth and innovation in the biotechnology sector.
Research collaboration with Roswell Park Gero partnered with Roswell Park Comprehensive Cancer Center on a study that investigated associations between aging and stress recovery, opening up opportunities to leverage insights from the study to develop targeted therapeutics for related conditions.
AI-driven drug discovery As an AI-focused drug discovery company, Gero leverages cutting-edge technology to identify novel drug targets applicable to multiple indications, presenting a compelling proposition for pharmaceutical companies seeking innovative solutions for complex diseases.
Strategic board appointment With the appointment of Yury Melnichek, co-founder of Bulba Ventures, to its board of directors, Gero gains valuable strategic guidance and industry expertise, potentially enhancing its positioning for future partnerships and collaborations.
51
$10M$50M
66$10M$50M
867$100M$1B
275$50M$100M
81$10MGero uses 8 technology products and services including Google Analytics, Yandex.Metrika, Cloudflare CDN, and more. Explore Gero's tech stack below.
| Gero Email Formats | Percentage |
| First.Last@gero.ai | 42% |
| FL@gero.ai | 8% |
| First.Last@gero.ai | 42% |
| FL@gero.ai | 8% |
Biotechnology ResearchCalifornia, United States51-200 Employees
We are a preclinical stage AI drug discovery company with a mission to eliminate age-related diseases We use AI to build clinically relevant disease phenotypes in real-world human data and identify diseases with shared biology. Then WES-enabled genetic study on these phenotypes allows us to discover novel targets applicable to several indications at once. You can find our publications here: https://gero.ai/publications
Company Overview
Media & News
Funding & FinancialsGero has raised a total of $6M of funding over 3 rounds. Their latest funding round was raised on Oct 18, 2023 in the amount of $6M.
Gero's revenue is in the range of $10M
Funding & FinancialsGero has raised a total of $6M of funding over 3 rounds. Their latest funding round was raised on Oct 18, 2023 in the amount of $6M.
Gero's revenue is in the range of $10M
1-888-653-2347 
support@leadiq.com